SARS CoV 2 News and Research

RSS

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

A recent study, currently available on bioRxiv* preprint server, shows that a novel protease inhibitor known as nirmatrelvir has potent activity against Omicron variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other variants evaluated in this paper – which supports its potential role in reducing the disease burden from coronavirus disease 2019 (COVID-19).

21 Jan 2022

COVID-19 vaccination does not impair fertility, suggests BU study

New findings by Boston University School of Public Health investigators indicate that COVID-19 vaccination does not impair fertility-;but males who become infected by the coronavirus may experience short-term reduced fertility.

21 Jan 2022

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

Iowa State University scientists may have uncovered an important clue that sheds light on why pigs don't get sick when exposed to the coronavirus

20 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

A validated risk-stratification system to manage COVID-19 outpatients

A group of researchers developed a risk-stratification system from existing scoring methods that are exclusively for outpatients.

20 Jan 2022

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Researchers present evidence for early community transmission of the SARS-CoV-2 Omicron variant in New Delhi, India.

20 Jan 2022

Research shows benefits of hybrid immunity to SARS-CoV-2

Researchers examine the effects of previous SARS-CoV-2 infections on the immunity offered by SARS-CoV-2 vaccination.

20 Jan 2022

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

A study by researchers at Mayo Clinic Cancer Center has found that patients with cancer who receive chemotherapy - and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells - may mount an inadequate immune response to COVID-19 vaccination.

20 Jan 2022

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

A recent study looked at the strength, durability and breadth of neutralizing antibody responses generated by breakthrough infections in individuals vaccinated against SARS-CoV2.

20 Jan 2022

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

SARS-CoV-2 was initially identified as a respiratory virus, but it can affect the entire body, including the nervous system.

20 Jan 2022

COVID-19 vaccination does not appear to impair fertility, study says

COVID-19 vaccination does not affect the chances of conceiving a child, according to a study of more than 2,000 couples that was funded by the National Institutes of Health.

20 Jan 2022

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

A new study suggests that coronaviruses such as SARS-CoV-2 depend on a furin cleavage site between the S1/S2 subunits to enhance viral infectivity.

20 Jan 2022

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

A new analysis parses out what scientists currently know about the Delta variant and predicts what the end of the COVID-19 pandemic might look like.

20 Jan 2022

RASCL: new analytic pipeline for investigating selective forces acting on viral genes in SARS-CoV-2 sequences

A study revealed a new analytical pipeline to assess the clades of SARS-CoV-2 by molecular sequence analysis.

20 Jan 2022

Determining COVID-19 vaccine effectiveness among health care workers in Wales

A new study revealed an overall high vaccine uptake and significant vaccine effectiveness of BNT162b2 against COVID-19, among healthcare workers in Wales.

20 Jan 2022

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Scientists at The University of Texas MD Anderson Cancer Center and Northwestern Medicine have identified natural extracellular vesicles containing the ACE2 protein (evACE2) in the blood of COVID-19 patients that can block infection from broad strains of SARS-CoV-2 virus in preclinical studies. The study was published today in Nature Communications.

20 Jan 2022

SARS CoV 2 News and Research

PAXLOVID shown to be highly effective against all SARS-CoV-2 variants

COVID-19 vaccination does not impair fertility, suggests BU study

Study uncovers clue to why pigs don't get sick when exposed to COVID-19

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

A validated risk-stratification system to manage COVID-19 outpatients

Indian study suggests significant decrease in protection from vaccine or natural immunity against Omicron variant

Research shows benefits of hybrid immunity to SARS-CoV-2

Cancer patients receiving treatment may mount inadequate immune response to COVID-19 vaccination

SARS-CoV-2 breakthrough infections elicit potent neutralizing antibody responses

Experts highlight the neurological effects of SARS-CoV-2 and the need for rigorous research

COVID-19 vaccination does not appear to impair fertility, study says

Researchers explore furin inhibitors as a potential tool for treating COVID-19 infection

Scientists explore the possibility of Omicron ending the COVID-19 pandemic

RASCL: new analytic pipeline for investigating selective forces acting on viral genes in SARS-CoV-2 sequences

Determining COVID-19 vaccine effectiveness among health care workers in Wales

Natural extracellular vesicles containing ACE2 protein could fight new SARS-CoV-2 variants

Prospective of graphene and graphene-based derivatives to combat SARS-CoV-2 infection

Development of a glycoprotein multi-epitope subunit vaccine candidate against South-African SARS-CoV-2 strains

Is COVID-19 mRNA vaccination in children associated with subsequent multisystemic hyper-inflammatory syndrome?

Antibodies to SARS-CoV-2 and infection risk in healthcare workers following mRNA vaccination

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News